Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Puig

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Expert Opinion on Biological Therapy|November 24, 2022
Biologic treatment of psoriasis in oncologic patientsLluís Rusiñol, Gemma Camiña-Conforto, Luis Puig
IEEE Transactions on Pattern Analysis and Machine Intelligence|September 10, 2015
Scale Space for Camera Invariant FeaturesLuis Puig, José J Guerrero, Kostas Daniilidis
Sensors (Basel, Switzerland)|October 17, 2013
Omnidirectional structured light in a flexible configurationCarmen Paniagua, Luis Puig, José J Guerrero
American Journal of Clinical Dermatology|August 12, 2022
Deucravacitinib for the Treatment of Psoriatic DiseaseAna Maria Lé, Luis Puig, Tiago Torres
The American Journal of Dermatopathology|December 2, 2014
Epidermolytic Hyperkeratosis: One More Pattern of Grover DiseaseMaria-Teresa Fernández-Figueras, Luis Puig, Aurelio Ariza
3D Printing and Additive Manufacturing|May 14, 2026
3D Printing Applications and Extended Realities in Medicine: Systematic ReviewCarlos Humberto Araujo, Javier Adolfo Aguirre, Luis Puig
JAMA Dermatology|July 23, 2020
Follmann Balanitis-An Atypical Form of Primary Cutaneous SyphilisXavier Cubiró, Jorge Nestor García-Pérez, Luis Puig
Clinicoeconomics and Outcomes Research : CEOR|March 7, 2014
Predictors of biologic treatment of psoriasis: a non-interventional studyLuis Puig, Tao Fan, Qian Ding, et al.
Dermatology and Therapy|May 14, 2021
Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or UstekinumabJo Lambert, Jes Birger Hansen, Anne Sohrt, et al.
Journal of the American Academy of Dermatology|June 9, 2019
Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator-controlled phase 3 AMAGINE-2 trialLuis Puig, Mark Lebwohl, Hervé Bachelez, et al.
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Expert Opinion on Biological Therapy|November 24, 2022
Biologic treatment of psoriasis in oncologic patientsLluís Rusiñol, Gemma Camiña-Conforto, Luis Puig
IEEE Transactions on Pattern Analysis and Machine Intelligence|September 10, 2015
Scale Space for Camera Invariant FeaturesLuis Puig, José J Guerrero, Kostas Daniilidis
Sensors (Basel, Switzerland)|October 17, 2013
Omnidirectional structured light in a flexible configurationCarmen Paniagua, Luis Puig, José J Guerrero
American Journal of Clinical Dermatology|August 12, 2022
Deucravacitinib for the Treatment of Psoriatic DiseaseAna Maria Lé, Luis Puig, Tiago Torres
The American Journal of Dermatopathology|December 2, 2014
Epidermolytic Hyperkeratosis: One More Pattern of Grover DiseaseMaria-Teresa Fernández-Figueras, Luis Puig, Aurelio Ariza
3D Printing and Additive Manufacturing|May 14, 2026
3D Printing Applications and Extended Realities in Medicine: Systematic ReviewCarlos Humberto Araujo, Javier Adolfo Aguirre, Luis Puig
JAMA Dermatology|July 23, 2020
Follmann Balanitis-An Atypical Form of Primary Cutaneous SyphilisXavier Cubiró, Jorge Nestor García-Pérez, Luis Puig
Clinicoeconomics and Outcomes Research : CEOR|March 7, 2014
Predictors of biologic treatment of psoriasis: a non-interventional studyLuis Puig, Tao Fan, Qian Ding, et al.
Dermatology and Therapy|May 14, 2021
Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or UstekinumabJo Lambert, Jes Birger Hansen, Anne Sohrt, et al.
Journal of the American Academy of Dermatology|June 9, 2019
Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator-controlled phase 3 AMAGINE-2 trialLuis Puig, Mark Lebwohl, Hervé Bachelez, et al.
Pageof 13